| Mrs Olga Maldonado, CNP | |
|
345 Ave Hostos, Mayaguez, PR 00680-1507 | |
| (787) 834-9600 | |
| Not Available |
| Full Name | Mrs Olga Maldonado |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Adult Health |
| Location | 345 Ave Hostos, Mayaguez, Puerto Rico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184649394 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2200X | Nurse Practitioner - Adult Health | 21136 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Olga Maldonado, CNP #3423 Juan J. Burgos, Nueva Vida, El Tuque, Ponce, PR 00728 Ph: (787) 284-0572 | Mrs Olga Maldonado, CNP 345 Ave Hostos, Mayaguez, PR 00680-1507 Ph: (787) 834-9600 |
News Archive
The incidence of sexual dysfunction in patients suffering from Benign Prostatic Hyperplasia (BPH) - or enlarged prostate - is nearly twice as high as treating physicians believe shows a new survey from the American Foundation for Urologic Diseases (AFUD) presented today at the American Urological Association annual meeting.
Oxford Gene Technology, The Molecular Genetics Company, has announced that it is now directly selling Cytocell Fluorescence In Situ Hybridisation products through several established affiliates of SysmexCorporation in Europe following its acquisition last year.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine and minimally invasive spine technologies and techniques, today announced the U.S. launch of its award-winning CASCADIA Interbody Systems, featuring Lamellar 3D Titanium Technology, during the 31st North American Spine Society (NASS) Annual Meeting, Oct. 26-29, 2016, in Boston at Booth #1615.
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, announced today the final results for its previously announced cash tender offer (the "Tender Offer") to purchase any and all of its 5.125% Senior Notes due 2010 and any and all of its 7.50% Senior Notes due 2011 (collectively, the "Notes").
Sirnaomics, Inc. and its affiliate Suzhou Sirnaomics Pharmaceutics, Co. Ltd., together with its partner Guangzhou Xiangxue Pharmaceutical, Co. Ltd., (SZSE: 300147), have formally submitted an Investigational New Drug (IND) Application to the China Food and Drug Administration for STP705, an anti-fibrosis RNA interference (RNAi) therapeutic for prevention and treatment of human skin hypertrophic scars.
› Verified 4 days ago
Mr. Raul Torres, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 345 Ave Hostos, Mayaguez, PR 00680 Phone: 787-834-6900 Fax: 787-265-8808 |